SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-035972
Filing Date
2017-02-09
Accepted
2017-02-09 15:20:32
Documents
2
Group Members
ANSBERT GADICKELUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV4 LLCMPM ASSET MANAGEMENT INVESTORS BV5 LLCMPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KGMPM BIOVENTURES IV GP LLCMPM BIOVENTURES IV LLCMPM BIOVENTURES V GP LLCMPM BIOVENTURES V LLCMPM BIOVENTURES V

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d311943dsc13ga.htm SC 13G/A 200136
2 EX-99.A d311943dex99a.htm EX-99.A 20147
  Complete submission text file 0001193125-17-035972.txt   222361
Mailing Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 617-425-9200
MPM BioVentures IV QP LP (Filed by) CIK: 0001358309 (see all company filings)

IRS No.: 204217788 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Subject) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87858 | Film No.: 17587247
SIC: 2834 Pharmaceutical Preparations